| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.17 | 9e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.16 | 9e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.27 | 1e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.29 | 3e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |